A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies

NCT04547049 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

232

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
MDS

Interventions

DRUG: Cytarabine
DRUG: Busulfan
DRUG: Cyclophosphamide
DRUG: Me-CCNU
DRUG: Rabbit antithymocyte globulin
PROCEDURE: Allogeneic HSCT
DRUG: Cyclosporin A
DRUG: Mycophenolate Mofetil
DRUG: MTX

Sponsor

First Affiliated Hospital of Zhejiang University